NR4A1 and breast cancer: 13. Kim JH, Im SA, Sim SH, Bananis E, Huang X, Kim HS, et al. Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer. J Breast Cancer. 2021;24:97-105.